1001-00004 · Ardent Capital Partners · Antitrust & Regulatory

cfius-voluntary-notice-draft-narrative.docx DOCUMENT M&A / Corporate

4 / 78 ← → ✕

PRIVILEGED & CONFIDENTIAL — ATTORNEY WORK PRODUCT — SUBJECT TO FURTHER REVIEW AND REVISION PRIOR TO SUBMISSION

DRAFT — NARRATIVE SECTION OF VOLUNTARY JOINT NOTICE TO THE COMMITTEE ON FOREIGN INVESTMENT IN THE UNITED STATES

Pursuant to Section 721 of the Defense Production Act of 1950, as Amended (50 U.S.C. § 4565), and 31 C.F.R. Part 800

NOTICE: This document is a DRAFT of the narrative section of a voluntary joint notice to the Committee on Foreign Investment in the United States ("CFIUS"). It is privileged and confidential attorney work product prepared by Calderwood & Harkness LLP in connection with the representation of Ardent Apex Holdings Inc. and Ardent Capital Partners III LP. This draft is subject to further review, revision, and approval by the Transaction Parties and their respective counsel prior to submission to CFIUS. Distribution of this draft is limited to authorized representatives of the Transaction Parties and their advisors. Unauthorized distribution, copying, or use of this document is strictly prohibited.

Right-click to update Table of Contents

PART I — INTRODUCTION AND SUMMARY OF THE TRANSACTION

1.1 Purpose of the Notice

This voluntary joint notice (this "Notice") is filed pursuant to Section 721 of the Defense Production Act of 1950, as amended by the Foreign Investment Risk Review Modernization Act of 2018 ("FIRRMA") (50 U.S.C. § 4565), and the regulations promulgated thereunder at 31 C.F.R. Part 800 (the "Regulations"). The Transaction Parties — Ardent Apex Holdings Inc. (the "Buyer") and Luminex Systems Holdings Inc. (the "Target") — respectfully submit this voluntary joint notice to the Committee on Foreign Investment in the United States ("CFIUS" or the "Committee") in connection with the proposed acquisition of all of the outstanding equity interests of Luminex Systems Holdings Inc. by Ardent Apex Holdings Inc., an indirect wholly owned subsidiary of Ardent Capital Partners III LP ("Ardent Capital" or the "Fund").

The Transaction Parties believe that the proposed transaction (the "Transaction") constitutes a "covered transaction" within the meaning of 31 C.F.R. § 800.213, as it will result in a change of control of a U.S. business — specifically, Luminex Systems Inc. ("Luminex US"), the primary U.S. operating subsidiary of the Target — through the indirect acquisition of Luminex Systems AG ("Luminex AG"), a Swiss Aktiengesellschaft, and its U.S. subsidiaries. Although the ultimate acquiring entity, Ardent Capital Partners III LP, is a Delaware limited partnership controlled by U.S. persons, the Transaction involves the acquisition of an entity chain that includes a Swiss operating parent (Luminex AG) and the participation of certain foreign-person co-investors and limited partners, as more fully described herein. As a result, and in light of Luminex US's contracts with the U.S. Department of Defense ("DOD"), the U.S. Department of Energy ("DOE"), and the U.S. General Services Administration ("GSA"), the Transaction Parties have determined that a voluntary joint notice is both appropriate and prudent.

The Transaction Parties respectfully request that CFIUS undertake a timely review of the proposed Transaction and grant clearance at the earliest practicable date. The Transaction Parties are fully committed to cooperation with CFIUS throughout the review process and stand ready to provide any additional information, documents, or access that the Committee or its member agencies may require. The Transaction Parties are also prepared to discuss and, where appropriate, implement mitigation measures to address any national security considerations that may arise in connection with the Transaction, as more fully described in Part VI below.

1.2 Transaction Overview

The Transaction is structured as a reverse triangular merger under the Delaware General Corporation Law (the "DGCL"). Ardent Apex Merger Sub Inc. ("Merger Sub"), a Delaware corporation formed solely for the purpose of effecting the Transaction and wholly owned by the Buyer, will merge with and into Luminex Systems Holdings Inc., with Luminex Systems Holdings Inc. surviving as a wholly owned subsidiary of the Buyer (the "Merger"). Upon consummation of the Merger, Merger Sub will cease to exist, and Luminex Systems Holdings Inc. will continue as the surviving corporation.

The aggregate equity consideration for the Transaction is $2,800,000,000 (two billion eight hundred million dollars), payable in cash, except for management rollover equity as described in Section 4.2 below. The per-share merger consideration is $20.00 per share of Luminex Systems Holdings Inc. common stock, based on approximately 140,000,000 fully diluted shares outstanding. The consideration represents a premium of approximately 32% over the volume-weighted average price of Luminex Holdings shares for the 30-day trading period ending March 21, 2025.

The Agreement and Plan of Merger (the "Merger Agreement") was executed by the parties on March 24, 2025, following approval by the boards of directors of Luminex Systems Holdings Inc. and Ardent Apex Holdings Inc. A copy of the fully executed Merger Agreement is attached hereto as Exhibit B-1. The Transaction is expected to close in the third quarter of 2025, with a target closing date in July or August 2025. The Merger Agreement provides for an outside date of September 10, 2025, which may be extended to December 10, 2025 if the sole unsatisfied condition to closing as of the initial outside date is the receipt of required regulatory approvals.

1.3 Other Pending Regulatory Filings

In addition to this Notice, the Transaction Parties have made, or intend to make, the following regulatory filings in connection with the Transaction:

1. Hart-Scott-Rodino Act Premerger Notification. A Notification and Report Form under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), was filed with the Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice on March 28, 2025 (Transaction No. HSR-20250328-4192). The initial 30-day waiting period under the HSR Act is expected to expire on April 27, 2025. Based on the overlap between the Luminex One procurement-automation module and the Vectis Solutions LLC procurement-automation SaaS platform (a portfolio company of Ardent Capital Partners II LP, a predecessor fund), the Transaction Parties anticipate that a Request for Additional Information and Documentary Material (a "Second Request") may be issued prior to the expiration of the initial waiting period.

2. Swiss FINMA/SECO Notification. A notification under Swiss financial market and foreign investment regulations was filed with the Swiss Financial Market Supervisory Authority ("FINMA") and the State Secretariat for Economic Affairs ("SECO") on April 7, 2025 (File No. 32-0973). This filing is required in connection with the change of control of Luminex Systems AG, a Swiss Aktiengesellschaft.

3. Bundeskartellamt Filing. A merger notification under Section 39 of the German Act Against Restraints of Competition (Gesetz gegen Wettbewerbsbeschränkungen, "GWB") is expected to be filed with the German Federal Cartel Office (Bundeskartellamt) on or about April 9, 2025 (File No. B6-34/25). This filing is required based on the revenue thresholds of Luminex Systems GmbH in Germany.

4. EU Foreign Subsidies Regulation Notification. A notification under Regulation (EU) 2022/2560 on foreign subsidies distorting the internal market (the "EU FSR") was filed with the European Commission on April 11, 2025 (Case No. FSR.M.2025-0412). This filing is required because the aggregate turnover of the parties exceeds €500 million in the European Union and the financial contributions from third-country governments to the parties exceed €50 million.

The Transaction Parties will promptly inform CFIUS of any material developments in connection with these parallel regulatory proceedings.

PART II — DESCRIPTION OF THE TRANSACTION PARTIES

2.1 The Buyer — Ardent Capital Partners III LP

2.1.1 Entity Information

The ultimate acquiring entity is Ardent Capital Partners III LP ("Ardent Capital" or the "Fund"), a Delaware limited partnership formed on January 15, 2023, for the purpose of making private equity investments. The Fund's principal office is located at 399 Park Avenue, 42nd Floor, New York, NY 10022. The Fund's Employer Identification Number is 87-3941026.

The general partner of the Fund is Ardent Capital GP III LLC (the "General Partner"), a Delaware limited liability company formed on January 8, 2023, with its principal office at the same address as the Fund. The General Partner has sole and exclusive authority to manage the business and affairs of the Fund, including all investment and disposition decisions, in accordance with the Fund's limited partnership agreement. The managing members of the General Partner are Theodore ("Ted") Hargrove and Victoria Langford, both of whom are U.S. citizens.

The Fund's registered agent in the State of Delaware is National Registered Agents of Delaware, Inc., located at 160 Greentree Drive, Suite 101, Dover, DE 19904. The Fund's limited partnership agreement is governed by the laws of the State of Delaware.

2.1.2 Business Description

Ardent Capital is a private equity investment firm focused on growth and buyout investments in three core sectors: enterprise technology, financial infrastructure, and healthcare information technology. The firm was founded in 2013 by Ted Hargrove and Victoria Langford, who together have over 50 years of combined experience in private equity and technology investing. Since its founding, Ardent Capital has raised and deployed capital through four flagship fund vehicles and various co-investment vehicles.

Fund III, with a 2023 vintage, has total capital commitments of $12.5 billion from a diversified base of institutional limited partners, including U.S. public and corporate pension funds, university endowments, foundations, insurance companies, and, as discussed in Section 2.1.4 below, certain sovereign wealth funds and state-affiliated investors. As of the date of this Notice, the Fund has deployed approximately $4.8 billion across seven platform investments, with the proposed Transaction representing the eighth platform investment.

Across its four flagship funds and co-investment vehicles, Ardent Capital has approximately $31.4 billion in firm-wide assets under management. The firm's investment strategy generally involves acquiring controlling or significant minority stakes in established technology companies with recurring revenue models, deploying operational improvements and growth capital, and exiting through strategic sales or initial public offerings over a three-to-seven-year hold period.

2.1.3 Principals and Investment Committee

The following individuals serve as principals of Ardent Capital and as members of the Fund's Investment Committee, which has sole authority to approve investment and disposition decisions on behalf of the Fund:

All five members of the Investment Committee are U.S. citizens and U.S. residents. No non-U.S. person has a seat on, or observer rights with respect to, the Investment Committee. The Investment Committee acts by majority vote, with Ted Hargrove holding a tie-breaking vote in the event of a deadlock. No limited partner, co-investor, advisory board member, or other person outside of the Investment Committee has the right to approve, disapprove, veto, or condition any investment or disposition decision of the Fund.

Biographical summaries of each Investment Committee member, including educational background, employment history, and professional qualifications, are available upon request and can be provided to CFIUS in connection with the review.

2.1.4 Limited Partner Base and Foreign Government-Connected Investors

The Fund's limited partner base consists of approximately 87 institutional investors, including U.S. state and municipal pension funds, corporate pension plans, university endowments, charitable foundations, insurance companies, funds of funds, family offices, and sovereign wealth funds. A complete schedule of all limited partners, including their names, jurisdictions of organization, commitment amounts, and foreign-person status, is attached hereto as Exhibit E-1.

Consistent with the requirements of the Regulations and CFIUS practice, the Transaction Parties have specifically identified and analyzed the following categories of investors in the Fund that may have connections to foreign governments:

Sovereign Wealth Funds and State-Affiliated Pension Funds. The Fund's limited partner base includes a small number of sovereign wealth funds and state-affiliated pension funds from allied and partner nations. The specific identities, commitment amounts, and foreign-government affiliations of these investors are set forth in Exhibit E-1. None of these limited partners has governance rights, board designation rights, veto rights, access to material non-public technical information of portfolio companies, or any rights beyond the customary economic and limited informational rights afforded to limited partners under the Fund's limited partnership agreement. The Fund's limited partnership agreement expressly provides that no limited partner shall participate in the management, control, or conduct of the Fund's business or have any authority or right to act on behalf of or bind the Fund.

Co-Investors. In connection with the Transaction, two co-investors will participate alongside the Fund:

(a) Northvale Sovereign Holdings Ltd. Northvale Sovereign Holdings Ltd. ("Northvale") has committed $200,000,000 in co-investment equity in connection with the Transaction. Northvale is an exempted limited company registered in the Cayman Islands. The primary point of contact for Northvale is Ahmad Al-Rashid, Head of Direct Investments. A detailed disclosure of Northvale's ultimate beneficial ownership and any foreign government connections is provided in Exhibit E-2. The Transaction Parties have conducted a thorough analysis of Northvale's ownership structure and governmental affiliations as part of the CFIUS analysis set forth in Part V below. Northvale's co-investment agreement provides for economic rights only, including the right to receive distributions pro rata with the Fund and other equity holders of Ardent Apex Holdings Inc., customary information rights (limited to periodic financial reporting on the investment), and tag-along and drag-along rights. Northvale does not have, and will not have, any board designation rights, veto rights, access to material non-public technical information of Luminex US or any other portfolio company, or any right to participate in or influence the management, operations, or strategic direction of the Target or its subsidiaries.

(b) Summit Ridge Capital Partners LP. Summit Ridge Capital Partners LP ("Summit Ridge") has committed $100,000,000 in co-investment equity in connection with the Transaction. Summit Ridge is a Delaware limited partnership with its principal office at 161 North Clark Street, Suite 4700, Chicago, IL 60601. The general partner of Summit Ridge is Summit Ridge Capital GP LLC, a Delaware limited liability company. The primary point of contact for Summit Ridge is Karen Lindstrom, Partner. Summit Ridge is a U.S.-domiciled institutional investor with no known foreign government connections. Like Northvale, Summit Ridge's co-investment agreement provides for economic rights only, with no governance, board, or veto rights.

2.1.5 Relevant Portfolio Companies

In accordance with CFIUS requirements, the Transaction Parties have identified the following portfolio company of Ardent Capital that is relevant to the Transaction or that may have U.S. government contracts or involvement with sensitive technology:

Vectis Solutions LLC. Vectis Solutions LLC ("Vectis") is a Delaware limited liability company with EIN 82-4910337. Vectis is headquartered at 4000 Shoreline Court, Suite 300, South San Francisco, CA 94080. The Chief Executive Officer of Vectis is Michael Parekh. Vectis is a cloud-based procurement-automation SaaS platform serving mid-market and enterprise customers. In fiscal year 2024, Vectis generated approximately $68,000,000 in revenue, representing approximately 7% of the U.S. procurement-automation SaaS market by revenue.

Vectis is a portfolio company of Ardent Capital Partners II LP, a predecessor fund of the Fund. Ardent Capital Partners II LP acquired a controlling interest in Vectis in 2020. Vectis is relevant to this Notice for two reasons. First, there is a product-market overlap between the Vectis procurement-automation SaaS platform and the procurement-automation module within the Luminex One platform, which is the subject of the HSR Act filing described in Section 1.3 above. The Transaction Parties estimate that Luminex holds approximately 18% of the U.S. procurement-automation SaaS market by revenue, and that the combined market share of Vectis and Luminex in this segment would be approximately 25%. Second, to the extent that Vectis holds any U.S. government contracts or handles government data, such information may be relevant to CFIUS's assessment of the broader Ardent Capital portfolio. The Transaction Parties are in the process of confirming whether Vectis holds any U.S. government contracts or subcontracts and will supplement this Notice with any relevant information.

The Transaction Parties are also in the process of reviewing the broader Ardent Capital portfolio, including Fund III portfolio companies and companies held by predecessor funds, to identify any additional portfolio companies with U.S. government contracts or involvement with sensitive technology. Any additional relevant portfolio companies will be identified in a supplemental filing if necessary.

2.2 Intermediate Acquisition Entities

2.2.1 Ardent Apex Holdings Inc.

Ardent Apex Holdings Inc. ("Apex Holdings") is a Delaware corporation formed on March 5, 2025, exclusively for the purpose of serving as the direct parent of Merger Sub and, following the closing of the Transaction, as the direct parent of the surviving corporation (Luminex Systems Holdings Inc.). Apex Holdings' EIN is 93-2178435. Its registered agent in the State of Delaware is National Registered Agents of Delaware, Inc., located at 160 Greentree Drive, Suite 101, Dover, DE 19904.

Apex Holdings is wholly owned by Ardent Capital Partners III LP. Following the closing of the Transaction, Apex Holdings will also issue equity interests to management rollover participants and co-investors, as described in Sections 4.2 and 4.4 below. Apex Holdings has not conducted any business operations since its formation, other than activities incidental to its formation and in connection with the Transaction. A copy of the Certificate of Incorporation of Apex Holdings is attached hereto as Exhibit C-1.

2.2.2 Ardent Apex Merger Sub Inc.

Ardent Apex Merger Sub Inc. ("Merger Sub") is a Delaware corporation formed on March 7, 2025, exclusively for the purpose of effecting the reverse triangular merger contemplated by the Merger Agreement. Merger Sub's EIN is 93-2178502. Its registered agent in the State of Delaware is National Registered Agents of Delaware, Inc., located at 160 Greentree Drive, Suite 101, Dover, DE 19904.

Merger Sub is wholly owned by Apex Holdings. Pursuant to the Merger Agreement, Merger Sub will merge with and into Luminex Systems Holdings Inc. at the effective time of the Merger, at which point Merger Sub will cease to exist as a separate entity. Merger Sub has not conducted any business operations since its formation, other than activities incidental to its formation and in connection with the Transaction. A copy of the Certificate of Incorporation of Merger Sub is attached hereto as Exhibit C-2.

2.3 The Target — Luminex Systems Holdings Inc.

2.3.1 Entity Information

Luminex Systems Holdings Inc. ("Luminex Holdings" or the "Target") is a Delaware corporation incorporated on June 14, 2021. The Target's EIN is 86-2547193. The Target's operational headquarters are located at 2100 Reston Gateway Drive, Suite 800, Reston, VA 20191. The Target's registered agent in the State of Delaware is Capitol Corporate Services, Inc., located at 1675 South Ashbury Asset Advisors, Suite B, Dover, DE 19901.

Luminex Holdings was established in 2021 as part of a reorganization of the Luminex corporate group (the "2021 Reorganization"), pursuant to which a new U.S. holding company (Luminex Holdings) was created as the ultimate parent entity of the Luminex group. Prior to the 2021 Reorganization, Luminex Systems AG, a Swiss Aktiengesellschaft, served as the ultimate parent of the group. In connection with the 2021 Reorganization, each outstanding share of Luminex AG was exchanged on a one-for-one basis for a share of Luminex Holdings common stock pursuant to a share exchange agreement. Following the 2021 Reorganization, Luminex Holdings became the direct parent of Luminex AG and the indirect parent of all operating subsidiaries, and Luminex AG became an intermediate holding company and operating entity within the group. The 2021 Reorganization was undertaken for capital markets, governance, and tax planning purposes.

A copy of the Certificate of Incorporation of Luminex Holdings, as amended, is attached hereto as Exhibit C-3.

2.3.2 Pre-Transaction Ownership

As of the date of this Notice, the outstanding equity of Luminex Systems Holdings Inc. is held as follows (on a fully diluted basis):

Ridgeline Growth Equity Fund II LP ("Ridgeline") is the majority stockholder of Luminex Holdings, holding approximately 52% of the fully diluted equity. Ridgeline is a Delaware limited partnership. Its general partner is Ridgeline Growth Equity GP II LLC, a Delaware limited liability company. The Managing Partner of Ridgeline is Jonathan Ashford. Ridgeline is a U.S.-domiciled growth equity fund focused on enterprise software and SaaS investments.

Meridian Venture Partners IV LP ("Meridian") is a significant minority stockholder, holding approximately 20% of the fully diluted equity. Meridian is a Delaware limited partnership. Its general partner is Meridian Venture GP IV LLC, a Delaware limited liability company. The Managing Partner of Meridian is Claire Fujimoto. Meridian is a U.S.-domiciled venture capital fund focused on early-stage and growth-stage technology investments.

Management and Employees collectively hold approximately 28% of the fully diluted equity of Luminex Holdings, consisting of common stock, restricted stock, and vested and unvested stock options. The key management holders are as follows:

• Dr. Stefan Kessler, Chief Executive Officer — approximately 8.5% (fully diluted)

• Annelise Gruber, Chief Financial Officer — approximately 4.2% (fully diluted)

• Dr. Markus Vogt, Chief Technology Officer — approximately 3.8% (fully diluted)

• Other management and employees — approximately 11.5% (fully diluted)

2.3.3 Board of Directors and Senior Management

The current members of the Board of Directors and senior management of Luminex Systems Holdings Inc. are as follows:

Board of Directors:

Senior Management:

2.4 Target Subsidiaries

The following entities are direct or indirect subsidiaries of Luminex Systems Holdings Inc.:

2.4.1 Luminex Systems AG (Intermediate Swiss Holding / Operating Entity)

Luminex Systems AG ("Luminex AG") is a Swiss Aktiengesellschaft registered in the Canton of Glenrock Assurance under Commercial Register No. CHE-284.391.057. Luminex AG's registered office and principal place of business are located at Bahnhofstrasse 71, 8001 Zürich, Switzerland. Luminex AG was founded in 2009 and served as the original parent entity of the Luminex group prior to the 2021 Reorganization. Following the 2021 Reorganization, Luminex AG became a wholly owned subsidiary of Luminex Holdings and now serves as the intermediate holding company for the group's non-U.S. operations, as well as an operating entity.

Luminex AG employs approximately 4,200 persons globally, including employees of its subsidiaries. For the fiscal year ended December 31, 2024, the Luminex group reported consolidated revenue of approximately $487,000,000, of which approximately $441,000,000 constituted annual recurring revenue ("ARR") from SaaS subscriptions and approximately $46,000,000 constituted professional services revenue. Consolidated adjusted EBITDA for fiscal year 2024 was approximately $121,800,000, representing a margin of approximately 25.0%.

2.4.2 Luminex Systems Inc. (U.S. Operating Subsidiary)

Luminex Systems Inc. ("Luminex US") is a Delaware corporation with EIN 86-2547210. Luminex US is headquartered at 2100 Reston Gateway Drive, Suite 800, Reston, VA 20191, co-located with the Target's operational headquarters. Luminex US is a wholly owned subsidiary of Luminex Systems Holdings Inc. and is the primary U.S. operating entity of the Luminex group.

Luminex US employs approximately 1,650 persons in the United States, including software engineers, product managers, sales and marketing professionals, customer success teams, and administrative personnel. For the fiscal year ended December 31, 2024, Luminex US generated U.S. revenue of approximately $194,800,000, representing approximately 40% of the Luminex group's consolidated global revenue.

Luminex US is the entity that holds the U.S. government contracts with DOD, DOE, and GSA, which are described in detail in Part III below. Luminex US is also the entity that is the principal focus of the CFIUS analysis in this Notice, as it constitutes the "U.S. business" within the meaning of the Regulations.

2.4.3 Luminex Systems UK Ltd.

Luminex Systems UK Ltd. ("Luminex UK") is a private limited company organized under the laws of England and Wales, with Company No. 12847362. Luminex UK's registered office is located at 14 Broadwick Street, London W1F 8HN, United Kingdom. Luminex UK is a wholly owned subsidiary of Luminex AG and serves as the regional operating entity for the United Kingdom and Nordics markets. Luminex UK employs approximately 380 persons.

2.4.4 Luminex Systems GmbH

Luminex Systems GmbH ("Veltronix GmbH") is a German Gesellschaft mit beschränkter Haftung (limited liability company) registered with the Munich Commercial Register under HRB No. HRB 247891. Veltronix GmbH's registered office is located at Leopoldstrasse 120, 80802 Munich, Germany. Veltronix GmbH is a wholly owned subsidiary of Luminex AG and serves as the regional operating entity for the DACH region (Germany, Austria, and Switzerland). For the fiscal year ended December 31, 2024, Veltronix GmbH generated revenue of approximately €67,000,000. Veltronix GmbH employs approximately 950 persons.

2.4.5 Luminex Systems Pte. Ltd.

Luminex Systems Pte. Ltd. ("Luminex Singapore") is a Singapore private limited company with Unique Entity Number (UEN) 201924781K. Luminex Singapore's registered office is located at 8 Marina Boulevard, #36-01, Singapore 018981. Luminex Singapore is a wholly owned subsidiary of Luminex AG and serves as the regional operating entity for the Asia-Pacific region. Luminex Singapore employs approximately 220 persons.

2.5 Seller Entities

The following entities and individuals will sell equity interests in Luminex Systems Holdings Inc. in connection with the Transaction:

Ridgeline Growth Equity Fund II LP. As the majority stockholder (52% fully diluted), Ridgeline will sell all of its shares of Luminex Holdings common stock and is expected to receive approximately $1,456,000,000 in cash merger consideration at the closing. Ridgeline will not retain any equity interest in the post-closing entity.

Meridian Venture Partners IV LP. As a significant minority stockholder (20% fully diluted), Meridian will sell all of its shares of Luminex Holdings common stock and is expected to receive approximately $560,000,000 in cash merger consideration at the closing. Meridian will not retain any equity interest in the post-closing entity.

Management Rollover Participants. Certain members of the Target's management team will participate in a management equity rollover in connection with the Transaction. Management holders collectively own approximately 28% of the fully diluted equity of Luminex Holdings, with an aggregate equity value of approximately $784,000,000 at the per-share merger consideration price of $20.00. Of this amount, management holders will receive cash consideration of approximately $378,980,000, and will roll over the remaining equity value of approximately $405,020,000 into equity interests in Ardent Apex Holdings Inc. The rollover equity will be subject to a stockholders agreement governing transfer restrictions, tag-along and drag-along rights, board composition, and information rights, as described in Section 4.4 below. The principal management rollover participants are Dr. Stefan Kessler, Annelise Gruber, and Dr. Markus Vogt.

2.6 Key Advisors

The following advisors are engaged by the Transaction Parties in connection with the Transaction:

Buyer's Advisors:

Seller's Advisors:

PART III — DESCRIPTION OF THE U.S. BUSINESS

3.1 Overview of Luminex Systems Inc. and Its Products

Luminex Systems Inc. is a cloud-based enterprise software-as-a-service ("SaaS") company that develops, markets, and supports the "Luminex One" platform. The Luminex One platform is an integrated suite of enterprise applications encompassing three core functional modules: (i) enterprise resource planning ("ERP"), (ii) procurement automation, and (iii) supply-chain analytics. The platform is designed to enable large and mid-market enterprises to manage end-to-end business processes, from financial management and human resources to procurement workflows, vendor management, inventory optimization, and supply-chain visibility.

The Luminex One platform is delivered exclusively as a cloud-hosted SaaS solution, with customers accessing the platform through web browsers and mobile applications on a subscription basis. The platform is built on a modern, multi-tenant cloud architecture leveraging Ridgeway Industries ("Meridian Technologies") and Crestline Systems infrastructure, with data residency options that allow customers to specify the geographic location of their data storage (including dedicated U.S. data centers for U.S. government and regulated-industry customers, as discussed further below).

Luminex's key markets are distributed globally, with the following approximate revenue breakdown by region for fiscal year 2024:

U.S. operations represent the single largest national market for the Luminex group. For the fiscal year ended December 31, 2024, Luminex US generated U.S. revenue of approximately $194,800,000, representing 40% of the Luminex group's consolidated global revenue of $487,000,000. The U.S. customer base includes large enterprises across the financial services, manufacturing, technology, healthcare, and public sector verticals.

Luminex US employs approximately 1,650 persons in the United States, primarily based at its operational headquarters in Reston, Virginia, with additional personnel in satellite offices in San Francisco, California, and Austin, Texas. The U.S. workforce includes software engineers, product managers, data scientists, sales and marketing professionals, customer success and support teams, professional services consultants, and administrative and corporate personnel.

The principal U.S. office is located at 2100 Reston Gateway Drive, Suite 800, Reston, VA 20191. Additional U.S. office locations include 100 Pine Street, Suite 3200, San Francisco, CA 94111, and 9600 Great Hills Trail, Suite 200W, Austin, TX 78759.

3.2 U.S. Government Contracts

Luminex US currently holds contracts with three U.S. federal agencies, which constitute the principal basis for the Transaction Parties' determination that CFIUS jurisdiction exists and that a voluntary joint notice is appropriate. Each of these contracts is summarized below, with additional detail provided in Exhibit D.

3.2.1 Department of Defense — Logistics Software Module

Luminex US provides a specialized logistics software module within the Luminex One platform to a component of the U.S. Department of Defense (the specific component is identified in Exhibit D-1, which is submitted under a request for confidential treatment). This logistics software module is used by the DOD component for supply-chain management, logistics tracking, inventory management, and procurement workflow automation. The module is a customized configuration of the Luminex One platform's supply-chain analytics and procurement-automation capabilities, tailored to meet the specific operational requirements of the DOD component.

The contract scope includes the initial procurement and deployment of the software module, including configuration, customization, data migration, and integration with existing DOD information systems, as well as ongoing SaaS subscription and maintenance services, including software updates, patches, security enhancements, and technical support. The contract was awarded following a competitive procurement process and is structured as a firm-fixed-price contract with option years.

In the performance of this contract, Luminex US personnel may have access to DOD logistics and supply-chain data, which may include controlled unclassified information ("CUI") as defined under 32 C.F.R. Part 2002. The nature and sensitivity of the data accessible to Luminex US personnel are described in greater detail in Exhibit D-1. Luminex US has implemented data-handling procedures and access controls consistent with NIST Special Publication 800-171 ("Protecting Controlled Unclassified Information in Nonfederal Systems and Organizations") and is in the process of achieving Cybersecurity Maturity Model Certification ("CMMC") Level 2 compliance.

To the extent that the DOD contract requires any facility security clearances or personnel security clearances under the National Industrial Security Program Operating Manual ("NISPOM"), the Transaction Parties will provide a detailed description of such clearances in a supplemental filing. The specific contract value, term, and additional details are set forth in Exhibit D-1.

3.2.2 Department of Energy — Procurement Platform

Luminex US provides its procurement-automation module to the U.S. Department of Energy for agency-wide procurement workflow management. The DOE uses the Luminex One procurement module to manage requisition, approval, sourcing, purchase order, and invoice processing workflows across multiple DOE offices and facilities. The platform enables DOE procurement professionals to automate routine procurement tasks, enforce compliance with federal acquisition regulations, and generate analytics and reporting on procurement activity.

In the performance of this contract, Luminex US personnel may have access to DOE procurement records, vendor databases, and related administrative data. While the majority of this data is administrative in nature, the Transaction Parties recognize that certain procurement records may contain information related to energy infrastructure, national laboratories, or other sensitive DOE programs. The Transaction Parties are in the process of conducting a detailed assessment of the sensitivity of the data accessible under this contract and will provide additional information as appropriate.

Luminex US complies with all applicable federal information security standards in connection with its DOE contract, including the Federal Information Security Modernization Act ("FISMA"), NIST Special Publication 800-53 ("Security and Privacy Controls for Information Systems and Organizations"), and applicable DOE-specific cybersecurity requirements. The specific contract value, term, security requirements, and additional details are set forth in Exhibit D-2.

3.2.3 General Services Administration — Enterprise License

Luminex US holds an enterprise license agreement with the U.S. General Services Administration, which enables multiple federal agencies to access the Luminex One platform through GSA's government-wide procurement vehicle. The GSA enterprise license agreement is structured as a blanket purchase agreement under GSA Schedule 70 (now consolidated into GSA's Multiple Award Schedule), allowing federal agencies to place task orders for Luminex One platform subscriptions, configuration services, and professional services through a streamlined procurement process.

The GSA enterprise license agreement significantly expands the potential scope of Luminex US's involvement with U.S. federal agencies, as it provides a procurement vehicle through which any federal civilian agency (and, in some cases, DOD components) may acquire Luminex One platform services. As of the date of this Notice, task orders have been placed under the GSA enterprise license agreement by several federal agencies, including but not limited to the Department of Health and Human Services, the Department of the Treasury, and the Small Business Administration. The full list of agencies that have placed task orders under the GSA enterprise license agreement is provided in Exhibit D-3.

The GSA enterprise license agreement carries broader implications for federal data handling, as each task order may involve different types of agency data with varying sensitivity levels. Luminex US maintains compliance with all applicable data-handling requirements under FISMA, FedRAMP (Luminex One holds a FedRAMP Moderate authorization through the Joint Authorization Board), and agency-specific security standards. The contract value, term, and additional details are set forth in Exhibit D-3.

3.3 Sensitive Technology and Data

The Transaction Parties have undertaken a thorough assessment of whether Luminex US produces, designs, tests, manufactures, fabricates, or develops any "critical technologies" within the meaning of 31 C.F.R. § 800.215. The term "critical technologies" includes, among other things, defense articles and defense services included on the United States Munitions List set forth in the International Traffic in Arms Regulations ("ITAR") (22 C.F.R. Parts 120–130), items included on the Commerce Control List set forth in the Export Administration Regulations ("EAR") (15 C.F.R. Part 774), and certain other controlled items.

Based on the Transaction Parties' analysis to date, the Luminex One platform is a commercial enterprise software application that does not appear to constitute a "critical technology" under any of the enumerated categories in 31 C.F.R. § 800.215. The platform is not listed on the United States Munitions List, is not believed to be controlled under the EAR (other than as EAR99 or possibly under the general software and technology categories applicable to commercially available software), and is not subject to ITAR controls. The Transaction Parties note, however, that the customized logistics module provided to DOD under the contract described in Section 3.2.1 above may involve technology or software that is subject to more detailed export control analysis, and the Transaction Parties are in the process of completing this analysis. Any additional findings will be provided to CFIUS in a supplemental filing.

The Transaction Parties have also assessed whether Luminex US maintains or collects "sensitive personal data" of U.S. citizens as defined under 31 C.F.R. § 800.241. The Luminex One platform is primarily an enterprise business application that processes business data (e.g., financial records, procurement data, supply-chain information, and vendor management data) rather than personal data of individual U.S. persons. However, to the extent that certain modules of the platform involve human resources or employee data of Luminex US's enterprise customers, or to the extent that federal agency data accessible through government contracts includes personally identifiable information ("PII") of government employees, the platform may process limited categories of personal data. The Transaction Parties are conducting a detailed data-mapping exercise to determine the precise types and volumes of personal data processed by Luminex US and will provide the results to CFIUS upon completion.

With respect to the Luminex One platform architecture and data security:

• Cloud Hosting: The Luminex One platform is hosted on Meridian Technologies and Crestline Systems cloud infrastructure, with multi-region deployment capabilities.

• Data Residency: For U.S. government customers, Luminex US maintains dedicated instances of the Luminex One platform hosted in U.S.-based data centers (specifically, Meridian Technologies GovCloud regions located in the continental United States). All data associated with U.S. government contracts is stored and processed exclusively within U.S.-based data centers, with no data replication or transfer to non-U.S. locations.

• Encryption: All data at rest is encrypted using AES-256 encryption, and all data in transit is encrypted using TLS 1.2 or higher. Encryption keys for government customer data are managed through Meridian Technologies Key Management Service (KMS) with customer-managed keys where required.

• Access Controls: Luminex US employs role-based access control ("RBAC"), multi-factor authentication ("MFA"), and least-privilege principles to restrict access to government customer data to authorized personnel only. Access logs are maintained and auditable.

• FedRAMP Authorization: The Luminex One platform holds a FedRAMP Moderate authorization through the Joint Authorization Board ("JAB"), which certifies compliance with NIST SP 800-53 security controls at the Moderate baseline level.

The Transaction Parties do not believe that any Luminex technology is currently subject to export controls under ITAR or the EAR beyond the general applicability of EAR99 classification to commercially available software. However, the Transaction Parties are completing a detailed export control classification review and will supplement this Notice with any relevant findings.

3.4 Critical Infrastructure

The Transaction Parties have analyzed whether Luminex US's services to DOD, DOE, and GSA implicate any of the 16 critical infrastructure sectors identified in Presidential Policy Directive 21 ("PPD-21"), which are relevant to the TID U.S. business analysis under the Regulations and to CFIUS's broader national security assessment.

Based on this analysis, the Transaction Parties have identified the following potential nexuses between Luminex US's operations and critical infrastructure sectors:

• Defense Industrial Base Sector. Luminex US's contract with DOD to provide a logistics software module for supply-chain management and logistics tracking has a direct nexus to the Defense Industrial Base sector. The DOD logistics software module supports the management and tracking of defense-related supply chains, and disruption or compromise of this module could potentially affect DOD logistics operations. The Transaction Parties recognize that this nexus is a significant factor in the CFIUS analysis and have proposed mitigation measures to address associated risks, as described in Part VI below.

• Energy Sector. Luminex US's contract with DOE to provide a procurement-automation platform has a potential nexus to the Energy sector. To the extent that DOE procurement records accessible through the Luminex One platform relate to energy infrastructure, national laboratories, or other sensitive energy programs, the platform's involvement in DOE procurement workflows may implicate Energy sector critical infrastructure considerations. The Transaction Parties are assessing the specific nature of the DOE data accessible through the contract and will provide additional detail.

• Critical Manufacturing and Transportation Systems Sectors. The Luminex One platform's supply-chain analytics functionality may have indirect relevance to the Critical Manufacturing and Transportation Systems sectors through downstream use by government customers. Specifically, to the extent that DOD or other federal agencies use the Luminex One platform to manage supply chains that include critical manufacturing inputs or transportation logistics, the platform's functionality may have a tangential connection to these sectors. The Transaction Parties note, however, that this connection is indirect and mediated by the government customer's own use of the platform, rather than a direct provision of critical infrastructure services by Luminex US.

The Transaction Parties are prepared to discuss these critical infrastructure nexuses with CFIUS and its member agencies in greater detail and to provide any additional information that may be requested.

3.5 Proximity to Sensitive Government Facilities

The Transaction Parties have assessed the geographic locations of Luminex US's offices and data center facilities for proximity to sensitive U.S. government installations. The principal U.S. office of Luminex US is located at 2100 Reston Gateway Drive, Suite 800, Reston, VA 20191, in the Dulles Technology Corridor of Northern Virginia. This location is within the Washington, D.C. metropolitan area and is in proximity to numerous DOD, intelligence community, and other federal government facilities, including but not limited to the Pentagon, the National Geospatial-intelligence Agency headquarters, and various intelligence community installations in Northern Virginia.

Luminex US also maintains satellite offices at 100 Pine Street, Suite 3200, San Francisco, CA 94111, and 9600 Great Hills Trail, Suite 200W, Austin, TX 78759. The Transaction Parties are not aware of any particular proximity concerns associated with these locations.

With respect to data centers, as noted in Section 3.3 above, Luminex US utilizes Meridian Technologies GovCloud regions for U.S. government customer data. These data centers are operated by Ridgeway Industries and are located in the continental United States. Luminex US does not own or operate any proprietary data center facilities.

The Transaction Parties are prepared to provide any additional information regarding the geographic locations of Luminex US's facilities that CFIUS may require.

PART IV — TRANSACTION STRUCTURE AND MECHANICS

4.1 Merger Structure

The Transaction is structured as a reverse triangular merger under the DGCL. The material steps of the Transaction are as follows:

1. Ardent Apex Merger Sub Inc. (a wholly owned subsidiary of Ardent Apex Holdings Inc.) will merge with and into Luminex Systems Holdings Inc. at the effective time of the Merger (the "Effective Time").

2. At the Effective Time, Merger Sub will cease to exist as a separate entity, and Luminex Systems Holdings Inc. will continue as the surviving corporation and a wholly owned subsidiary of Ardent Apex Holdings Inc.

3. At the Effective Time, each share of Luminex Holdings common stock outstanding immediately prior to the Effective Time (other than shares held by stockholders who have validly exercised appraisal rights under DGCL Section 262, shares held by Luminex Holdings as treasury shares, and shares subject to management rollover agreements) will be converted into the right to receive $20.00 per share in cash, without interest.

4. Shares subject to management rollover agreements will be exchanged for equity interests in Ardent Apex Holdings Inc. in accordance with the terms of the applicable rollover agreements, as described in Section 4.2 below.

Following the closing of the Transaction, the post-closing organizational structure will be as follows:

Ardent Capital Partners III LP (Delaware limited partnership; ultimate controlling entity)

Ardent Apex Holdings Inc. (Delaware corporation; direct parent)

Luminex Systems Holdings Inc. (Delaware corporation; surviving corporation)

Luminex Systems AG (Swiss Aktiengesellschaft; intermediate holding / operating entity)

Luminex Systems Inc. (Delaware corporation; U.S. operating subsidiary) Luminex Systems UK Ltd. (England and Wales; UK / Nordics operating subsidiary) Luminex Systems GmbH (German GmbH; DACH operating subsidiary) Luminex Systems Pte. Ltd. (Singapore; APAC operating subsidiary)

A detailed pre-transaction and post-transaction organizational chart is attached hereto as Exhibit A.

4.2 Consideration

The aggregate equity consideration for the Transaction is $2,800,000,000, reflecting a per-share merger consideration of $20.00 multiplied by approximately 140,000,000 fully diluted shares. The consideration is payable in cash, except for the management rollover equity described below.

The allocation of merger consideration among the stockholder groups is as follows:

The management rollover equity of approximately $405,020,000 will be contributed by the management rollover participants (principally Dr. Stefan Kessler, Annelise Gruber, and Dr. Markus Vogt, together with other participating management and employees) in exchange for equity interests in Ardent Apex Holdings Inc., the post-closing parent entity. The rollover equity will represent a minority interest in Apex Holdings and will be subject to the terms of a stockholders agreement, as described in Section 4.4 below.

The Merger Agreement provides for a purchase price escrow of $140,000,000, representing 5% of the aggregate equity consideration. The escrow will be held by Continental Fiduciary Trust Company, as escrow agent, for a period of 18 months following the closing, to secure the sellers' indemnification obligations under the Merger Agreement with respect to breaches of representations and warranties, covenants, and other specified matters.

4.3 Financing

The Transaction will be financed through a combination of equity and debt as follows:

Sources of Funds:

Uses of Funds:

Debt Financing. The senior secured Term Loan B of $1,200,000,000 will be provided by Stonebridge Credit Partners LLC as lead arranger and administrative agent, with Birchwood Capital Finance LLC ($350,000,000 hold) and Ironvale Credit Fund III LP ($250,000,000 hold) as co-lenders. The remaining $250,000,000 of the Term Loan B is expected to be syndicated to additional institutional lenders in the ordinary course. The Term Loan B will bear interest at a rate of SOFR plus 475 basis points, with a seven-year maturity. The commitment letter for the senior secured credit facility was executed on March 8, 2025 (Stonebridge Reference No. SC-2025-0312-AC). A copy of the commitment letter is attached hereto as Exhibit B-4.

The subordinated notes of $300,000,000 will be issued to Crestline Mezzanine Partners II LP. The subordinated notes will bear interest at a rate of 11.5% per annum on a PIK toggle basis, with an eight-year maturity. A copy of the subordinated note purchase agreement is attached hereto as Exhibit B-5.

The revolving credit facility of $200,000,000 will be provided by Stonebridge Credit Partners LLC as administrative agent, as part of the senior secured credit facility. The revolving credit facility is expected to be undrawn at the closing and is intended to be available for general corporate and working capital purposes post-closing.

Equity Financing. The equity financing for the Transaction consists of (i) the Fund equity commitment of $695,980,000 from Ardent Capital Partners III LP, (ii) the management rollover equity of approximately $405,020,000, and (iii) co-investment equity of $300,000,000 ($200,000,000 from Northvale and $100,000,000 from Summit Ridge). Copies of the equity commitment letter from Ardent Capital Partners III LP and the co-investment agreements with Northvale and Summit Ridge are attached hereto as Exhibits B-2 and B-3, respectively.

4.4 Post-Closing Governance

Following the closing of the Transaction, Ardent Capital will exercise control over the post-closing entity structure through the following governance mechanisms:

Ardent Capital GP III LLC (the General Partner of the Fund) will have sole and exclusive authority to manage the business and affairs of Ardent Capital Partners III LP, including the exercise of the Fund's rights as the controlling stockholder of Ardent Apex Holdings Inc. The managing members of the General Partner — Ted Hargrove and Victoria Langford — are U.S. citizens and will continue to exercise ultimate decision-making authority over the Fund's investment and governance activities.

Board of Directors of Ardent Apex Holdings Inc. The board of directors of Apex Holdings will be designated by Ardent Capital, in its capacity as the controlling stockholder. The initial post-closing board is expected to consist of five directors, of whom three will be designated by Ardent Capital (including Ted Hargrove and Victoria Langford), one will be an independent director, and one will be Dr. Stefan Kessler (in his capacity as CEO and management equity holder). No co-investor, limited partner, or other third party will have the right to designate a member of the board of directors.

Management Rollover Participants. Dr. Stefan Kessler, Annelise Gruber, and Dr. Markus Vogt will hold minority equity interests in Apex Holdings through the management rollover and will continue in their current management roles. Their equity interests will be governed by a stockholders agreement that provides for customary transfer restrictions (including restrictions on transfer without Ardent Capital's consent), tag-along and drag-along rights, and limited information rights. The management rollover participants will not have board designation rights (other than Dr. Kessler's seat as described above), veto rights over material corporate actions, or any other governance rights that would constitute "control" within the meaning of the Regulations.

Co-Investor Rights. Northvale and Summit Ridge will hold minority equity interests in Apex Holdings through the co-investment. Their rights are limited to economic rights (distributions pro rata), customary information rights (periodic financial reporting), and tag-along and drag-along rights. Neither Northvale nor Summit Ridge will have board designation rights, veto rights, access to material non-public technical information of Luminex US, or any right to participate in or influence the management, operations, or strategic direction of the post-closing entity or its subsidiaries.

4.5 Conditions to Closing

The closing of the Transaction is subject to the satisfaction or waiver of the following conditions precedent, as set forth in the Merger Agreement:

(a) Regulatory Approvals. Receipt of the following regulatory approvals or expiration of applicable waiting periods: (i) HSR Act clearance (expiration or early termination of the waiting period, or compliance with any Second Request); (ii) CFIUS clearance (written notification from CFIUS that the Committee has concluded its review and determined that there are no unresolved national security concerns, or that the Committee has concluded action under Section 721); (iii) Swiss FINMA/SECO clearance; (iv) Bundeskartellamt clearance; and (v) EU Foreign Subsidies Regulation clearance.

(b) No Material Adverse Effect. No material adverse effect shall have occurred with respect to the Target between the date of the Merger Agreement and the closing date.

(c) Bring-Down of Representations and Warranties. The representations and warranties of each party contained in the Merger Agreement shall be true and correct in all material respects (or, with respect to representations qualified by materiality, in all respects) as of the closing date.

(d) Compliance with Covenants. Each party shall have complied in all material respects with its covenants and obligations under the Merger Agreement.

(e) No Injunctions or Restraints. No law, order, injunction, or decree shall have been enacted, entered, promulgated, or enforced by any governmental authority that prohibits, restrains, or makes illegal the consummation of the Transaction.

The Merger Agreement provides for an outside date of September 10, 2025, after which either party may terminate the agreement if the closing has not occurred. The outside date is automatically extended to December 10, 2025 if the sole unsatisfied condition to closing as of September 10, 2025 is the receipt of one or more required regulatory approvals and all other conditions to closing have been satisfied or are capable of being satisfied.

PART V — BASIS FOR COVERED TRANSACTION DETERMINATION

5.1 Statutory and Regulatory Framework

Section 721 of the Defense Production Act of 1950, as amended by FIRRMA (50 U.S.C. § 4565), authorizes the President of the United States, acting through CFIUS, to review certain transactions involving foreign investment in the United States for national security implications. The implementing regulations, set forth at 31 C.F.R. Part 800, define the scope of "covered transactions" that are subject to CFIUS jurisdiction and establish the procedures for voluntary notices, declarations, and reviews.

Under 31 C.F.R. § 800.213, a "covered transaction" includes any transaction by or with any foreign person that could result in foreign control of any U.S. business, as well as certain non-controlling investments by foreign persons in a "TID U.S. business" (i.e., a U.S. business that produces, designs, tests, manufactures, fabricates, or develops one or more critical technologies; performs certain functions with respect to covered investment critical infrastructure; or maintains or collects sensitive personal data of U.S. citizens).

The Transaction Parties have analyzed the proposed Transaction under this framework and, for the reasons set forth below, have concluded that the Transaction warrants a voluntary joint notice to CFIUS.

5.2 Foreign Person Analysis

The analysis of whether the Transaction involves a "foreign person" within the meaning of 31 C.F.R. § 800.224 requires a careful examination of the acquiring entity chain and the identity and governance rights of all investors in the acquiring structure.

Ardent Capital Partners III LP and Its General Partner. The ultimate acquiring entity, Ardent Capital Partners III LP, is a Delaware limited partnership. Its general partner, Ardent Capital GP III LLC, is a Delaware limited liability company. The managing members of the General Partner — Ted Hargrove and Victoria Langford — are U.S. citizens and U.S. residents. All five members of the Fund's Investment Committee are U.S. citizens. The Fund is organized, headquartered, and managed in the United States. On its face, the Fund and its General Partner are U.S. persons.

Luminex Systems AG — Swiss Entity in the Acquisition Chain. The Transaction involves the indirect acquisition of Luminex Systems AG, a Swiss Aktiengesellschaft, which is the direct parent of Luminex US and the other operating subsidiaries. Following the 2021 Reorganization, Luminex AG became a wholly owned subsidiary of Luminex Holdings (a Delaware corporation). The post-closing structure places Luminex AG within a chain controlled by Ardent Capital (a U.S. fund), with Ardent Apex Holdings Inc. (a Delaware corporation) as the direct parent of Luminex Holdings, which in turn is the direct parent of Luminex AG. Although Luminex AG is a Swiss entity, it will be controlled post-closing by U.S. persons through the Ardent Capital fund structure. The CFIUS analysis therefore focuses on whether any foreign person within the Ardent Capital fund structure obtains "control" or a covered non-controlling investment interest in the U.S. business.

Northvale Sovereign Holdings Ltd. Northvale is an exempted limited company registered in the Cayman Islands. The primary point of contact for Northvale is Ahmad Al-Rashid, Head of Direct Investments. A detailed disclosure of Northvale's ultimate beneficial ownership and any foreign government connections is provided in Exhibit E-2. The Transaction Parties have assessed whether Northvale or its beneficial owners constitute a "foreign person"

PRIVILEGED & CONFIDENTIAL — ATTORNEY WORK PRODUCT — SUBJECT TO FURTHER REVIEW AND REVISION PRIOR TO SUBMISSION
DRAFT — NARRATIVE SECTION OF VOLUNTARY JOINT NOTICE TO THE COMMITTEE ON FOREIGN INVESTMENT IN THE UNITED STATES
Pursuant to Section 721 of the Defense Production Act of 1950, as Amended (50 U.S.C. § 4565), and 31 C.F.R. Part 800
NOTICE: This document is a DRAFT of the narrative section of a voluntary joint notice to the Committee on Foreign Investment in the United States ("CFIUS"). It is privileged and confidential attorney work product prepared by Calderwood & Harkness LLP in connection with the representation of Ardent Apex Holdings Inc. and Ardent Capital Partners III LP. This draft is subject to further review, revision, and approval by the Transaction Parties and their respective counsel prior to submission to CFIUS. Distribution of this draft is limited to authorized representatives of the Transaction Parties and their advisors. Unauthorized distribution, copying, or use of this document is strictly prohibited.
Right-click to update Table of Contents
PART I — INTRODUCTION AND SUMMARY OF THE TRANSACTION
1.1 Purpose of the Notice
This voluntary joint notice (this "Notice") is filed pursuant to Section 721 of the Defense Production Act of 1950, as amended by the Foreign Investment Risk Review Modernization Act of 2018 ("FIRRMA") (50 U.S.C. § 4565), and the regulations promulgated thereunder at 31 C.F.R. Part 800 (the "Regulations"). The Transaction Parties — Ardent Apex Holdings Inc. (the "Buyer") and Luminex Systems Holdings Inc. (the "Target") — respectfully submit this voluntary joint notice to the Committee on Foreign Investment in the United States ("CFIUS" or the "Committee") in connection with the proposed acquisition of all of the outstanding equity interests of Luminex Systems Holdings Inc. by Ardent Apex Holdings Inc., an indirect wholly owned subsidiary of Ardent Capital Partners III LP ("Ardent Capital" or the "Fund").
The Transaction Parties believe that the proposed transaction (the "Transaction") constitutes a "covered transaction" within the meaning of 31 C.F.R. § 800.213, as it will result in a change of control of a U.S. business — specifically, Luminex Systems Inc. ("Luminex US"), the primary U.S. operating subsidiary of the Target — through the indirect acquisition of Luminex Systems AG ("Luminex AG"), a Swiss Aktiengesellschaft, and its U.S. subsidiaries. Although the ultimate acquiring entity, Ardent Capital Partners III LP, is a Delaware limited partnership controlled by U.S. persons, the Transaction involves the acquisition of an entity chain that includes a Swiss operating parent (Luminex AG) and the participation of certain foreign-person co-investors and limited partners, as more fully described herein. As a result, and in light of Luminex US's contracts with the U.S. Department of Defense ("DOD"), the U.S. Department of Energy ("DOE"), and the U.S. General Services Administration ("GSA"), the Transaction Parties have determined that a voluntary joint notice is both appropriate and prudent.
The Transaction Parties respectfully request that CFIUS undertake a timely review of the proposed Transaction and grant clearance at the earliest practicable date. The Transaction Parties are fully committed to cooperation with CFIUS throughout the review process and stand ready to provide any additional information, documents, or access that the Committee or its member agencies may require. The Transaction Parties are also prepared to discuss and, where appropriate, implement mitigation measures to address any national security considerations that may arise in connection with the Transaction, as more fully described in Part VI below.
1.2 Transaction Overview
The Transaction is structured as a reverse triangular merger under the Delaware General Corporation Law (the "DGCL"). Ardent Apex Merger Sub Inc. ("Merger Sub"), a Delaware corporation formed solely for the purpose of effecting the Transaction and wholly owned by the Buyer, will merge with and into Luminex Systems Holdings Inc., with Luminex Systems Holdings Inc. surviving as a wholly owned subsidiary of the Buyer (the "Merger"). Upon consummation of the Merger, Merger Sub will cease to exist, and Luminex Systems Holdings Inc. will continue as the surviving corporation.
The aggregate equity consideration for the Transaction is $2,800,000,000 (two billion eight hundred million dollars), payable in cash, except for management rollover equity as described in Section 4.2 below. The per-share merger consideration is $20.00 per share of Luminex Systems Holdings Inc. common stock, based on approximately 140,000,000 fully diluted shares outstanding. The consideration represents a premium of approximately 32% over the volume-weighted average price of Luminex Holdings shares for the 30-day trading period ending March 21, 2025.
The Agreement and Plan of Merger (the "Merger Agreement") was executed by the parties on March 24, 2025, following approval by the boards of directors of Luminex Systems Holdings Inc. and Ardent Apex Holdings Inc. A copy of the fully executed Merger Agreement is attached hereto as Exhibit B-1. The Transaction is expected to close in the third quarter of 2025, with a target closing date in July or August 2025. The Merger Agreement provides for an outside date of September 10, 2025, which may be extended to December 10, 2025 if the sole unsatisfied condition to closing as of the initial outside date is the receipt of required regulatory approvals.
1.3 Other Pending Regulatory Filings
In addition to this Notice, the Transaction Parties have made, or intend to make, the following regulatory filings in connection with the Transaction:
1. Hart-Scott-Rodino Act Premerger Notification. A Notification and Report Form under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), was filed with the Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice on March 28, 2025 (Transaction No. HSR-20250328-4192). The initial 30-day waiting period under the HSR Act is expected to expire on April 27, 2025. Based on the overlap between the Luminex One procurement-automation module and the Vectis Solutions LLC procurement-automation SaaS platform (a portfolio company of Ardent Capital Partners II LP, a predecessor fund), the Transaction Parties anticipate that a Request for Additional Information and Documentary Material (a "Second Request") may be issued prior to the expiration of the initial waiting period.
2. Swiss FINMA/SECO Notification. A notification under Swiss financial market and foreign investment regulations was filed with the Swiss Financial Market Supervisory Authority ("FINMA") and the State Secretariat for Economic Affairs ("SECO") on April 7, 2025 (File No. 32-0973). This filing is required in connection with the change of control of Luminex Systems AG, a Swiss Aktiengesellschaft.
3. Bundeskartellamt Filing. A merger notification under Section 39 of the German Act Against Restraints of Competition (Gesetz gegen Wettbewerbsbeschränkungen, "GWB") is expected to be filed with the German Federal Cartel Office (Bundeskartellamt) on or about April 9, 2025 (File No. B6-34/25). This filing is required based on the revenue thresholds of Luminex Systems GmbH in Germany.
4. EU Foreign Subsidies Regulation Notification. A notification under Regulation (EU) 2022/2560 on foreign subsidies distorting the internal market (the "EU FSR") was filed with the European Commission on April 11, 2025 (Case No. FSR.M.2025-0412). This filing is required because the aggregate turnover of the parties exceeds €500 million in the European Union and the financial contributions from third-country governments to the parties exceed €50 million.
The Transaction Parties will promptly inform CFIUS of any material developments in connection with these parallel regulatory proceedings.
PART II — DESCRIPTION OF THE TRANSACTION PARTIES
2.1 The Buyer — Ardent Capital Partners III LP
2.1.1 Entity Information
The ultimate acquiring entity is Ardent Capital Partners III LP ("Ardent Capital" or the "Fund"), a Delaware limited partnership formed on January 15, 2023, for the purpose of making private equity investments. The Fund's principal office is located at 399 Park Avenue, 42nd Floor, New York, NY 10022. The Fund's Employer Identification Number is 87-3941026.
The general partner of the Fund is Ardent Capital GP III LLC (the "General Partner"), a Delaware limited liability company formed on January 8, 2023, with its principal office at the same address as the Fund. The General Partner has sole and exclusive authority to manage the business and affairs of the Fund, including all investment and disposition decisions, in accordance with the Fund's limited partnership agreement. The managing members of the General Partner are Theodore ("Ted") Hargrove and Victoria Langford, both of whom are U.S. citizens.
The Fund's registered agent in the State of Delaware is National Registered Agents of Delaware, Inc., located at 160 Greentree Drive, Suite 101, Dover, DE 19904. The Fund's limited partnership agreement is governed by the laws of the State of Delaware.
2.1.2 Business Description
Ardent Capital is a private equity investment firm focused on growth and buyout investments in three core sectors: enterprise technology, financial infrastructure, and healthcare information technology. The firm was founded in 2013 by Ted Hargrove and Victoria Langford, who together have over 50 years of combined experience in private equity and technology investing. Since its founding, Ardent Capital has raised and deployed capital through four flagship fund vehicles and various co-investment vehicles.
Fund III, with a 2023 vintage, has total capital commitments of $12.5 billion from a diversified base of institutional limited partners, including U.S. public and corporate pension funds, university endowments, foundations, insurance companies, and, as discussed in Section 2.1.4 below, certain sovereign wealth funds and state-affiliated investors. As of the date of this Notice, the Fund has deployed approximately $4.8 billion across seven platform investments, with the proposed Transaction representing the eighth platform investment.
Across its four flagship funds and co-investment vehicles, Ardent Capital has approximately $31.4 billion in firm-wide assets under management. The firm's investment strategy generally involves acquiring controlling or significant minority stakes in established technology companies with recurring revenue models, deploying operational improvements and growth capital, and exiting through strategic sales or initial public offerings over a three-to-seven-year hold period.
2.1.3 Principals and Investment Committee
The following individuals serve as principals of Ardent Capital and as members of the Fund's Investment Committee, which has sole authority to approve investment and disposition decisions on behalf of the Fund:
All five members of the Investment Committee are U.S. citizens and U.S. residents. No non-U.S. person has a seat on, or observer rights with respect to, the Investment Committee. The Investment Committee acts by majority vote, with Ted Hargrove holding a tie-breaking vote in the event of a deadlock. No limited partner, co-investor, advisory board member, or other person outside of the Investment Committee has the right to approve, disapprove, veto, or condition any investment or disposition decision of the Fund.
Biographical summaries of each Investment Committee member, including educational background, employment history, and professional qualifications, are available upon request and can be provided to CFIUS in connection with the review.
2.1.4 Limited Partner Base and Foreign Government-Connected Investors
The Fund's limited partner base consists of approximately 87 institutional investors, including U.S. state and municipal pension funds, corporate pension plans, university endowments, charitable foundations, insurance companies, funds of funds, family offices, and sovereign wealth funds. A complete schedule of all limited partners, including their names, jurisdictions of organization, commitment amounts, and foreign-person status, is attached hereto as Exhibit E-1.
Consistent with the requirements of the Regulations and CFIUS practice, the Transaction Parties have specifically identified and analyzed the following categories of investors in the Fund that may have connections to foreign governments:
Sovereign Wealth Funds and State-Affiliated Pension Funds. The Fund's limited partner base includes a small number of sovereign wealth funds and state-affiliated pension funds from allied and partner nations. The specific identities, commitment amounts, and foreign-government affiliations of these investors are set forth in Exhibit E-1. None of these limited partners has governance rights, board designation rights, veto rights, access to material non-public technical information of portfolio companies, or any rights beyond the customary economic and limited informational rights afforded to limited partners under the Fund's limited partnership agreement. The Fund's limited partnership agreement expressly provides that no limited partner shall participate in the management, control, or conduct of the Fund's business or have any authority or right to act on behalf of or bind the Fund.
Co-Investors. In connection with the Transaction, two co-investors will participate alongside the Fund:
(a) Northvale Sovereign Holdings Ltd. Northvale Sovereign Holdings Ltd. ("Northvale") has committed $200,000,000 in co-investment equity in connection with the Transaction. Northvale is an exempted limited company registered in the Cayman Islands. The primary point of contact for Northvale is Ahmad Al-Rashid, Head of Direct Investments. A detailed disclosure of Northvale's ultimate beneficial ownership and any foreign government connections is provided in Exhibit E-2. The Transaction Parties have conducted a thorough analysis of Northvale's ownership structure and governmental affiliations as part of the CFIUS analysis set forth in Part V below. Northvale's co-investment agreement provides for economic rights only, including the right to receive distributions pro rata with the Fund and other equity holders of Ardent Apex Holdings Inc., customary information rights (limited to periodic financial reporting on the investment), and tag-along and drag-along rights. Northvale does not have, and will not have, any board designation rights, veto rights, access to material non-public technical information of Luminex US or any other portfolio company, or any right to participate in or influence the management, operations, or strategic direction of the Target or its subsidiaries.
(b) Summit Ridge Capital Partners LP. Summit Ridge Capital Partners LP ("Summit Ridge") has committed $100,000,000 in co-investment equity in connection with the Transaction. Summit Ridge is a Delaware limited partnership with its principal office at 161 North Clark Street, Suite 4700, Chicago, IL 60601. The general partner of Summit Ridge is Summit Ridge Capital GP LLC, a Delaware limited liability company. The primary point of contact for Summit Ridge is Karen Lindstrom, Partner. Summit Ridge is a U.S.-domiciled institutional investor with no known foreign government connections. Like Northvale, Summit Ridge's co-investment agreement provides for economic rights only, with no governance, board, or veto rights.
2.1.5 Relevant Portfolio Companies
In accordance with CFIUS requirements, the Transaction Parties have identified the following portfolio company of Ardent Capital that is relevant to the Transaction or that may have U.S. government contracts or involvement with sensitive technology:
Vectis Solutions LLC. Vectis Solutions LLC ("Vectis") is a Delaware limited liability company with EIN 82-4910337. Vectis is headquartered at 4000 Shoreline Court, Suite 300, South San Francisco, CA 94080. The Chief Executive Officer of Vectis is Michael Parekh. Vectis is a cloud-based procurement-automation SaaS platform serving mid-market and enterprise customers. In fiscal year 2024, Vectis generated approximately $68,000,000 in revenue, representing approximately 7% of the U.S. procurement-automation SaaS market by revenue.
Vectis is a portfolio company of Ardent Capital Partners II LP, a predecessor fund of the Fund. Ardent Capital Partners II LP acquired a controlling interest in Vectis in 2020. Vectis is relevant to this Notice for two reasons. First, there is a product-market overlap between the Vectis procurement-automation SaaS platform and the procurement-automation module within the Luminex One platform, which is the subject of the HSR Act filing described in Section 1.3 above. The Transaction Parties estimate that Luminex holds approximately 18% of the U.S. procurement-automation SaaS market by revenue, and that the combined market share of Vectis and Luminex in this segment would be approximately 25%. Second, to the extent that Vectis holds any U.S. government contracts or handles government data, such information may be relevant to CFIUS's assessment of the broader Ardent Capital portfolio. The Transaction Parties are in the process of confirming whether Vectis holds any U.S. government contracts or subcontracts and will supplement this Notice with any relevant information.
The Transaction Parties are also in the process of reviewing the broader Ardent Capital portfolio, including Fund III portfolio companies and companies held by predecessor funds, to identify any additional portfolio companies with U.S. government contracts or involvement with sensitive technology. Any additional relevant portfolio companies will be identified in a supplemental filing if necessary.
2.2 Intermediate Acquisition Entities
2.2.1 Ardent Apex Holdings Inc.
Ardent Apex Holdings Inc. ("Apex Holdings") is a Delaware corporation formed on March 5, 2025, exclusively for the purpose of serving as the direct parent of Merger Sub and, following the closing of the Transaction, as the direct parent of the surviving corporation (Luminex Systems Holdings Inc.). Apex Holdings' EIN is 93-2178435. Its registered agent in the State of Delaware is National Registered Agents of Delaware, Inc., located at 160 Greentree Drive, Suite 101, Dover, DE 19904.
Apex Holdings is wholly owned by Ardent Capital Partners III LP. Following the closing of the Transaction, Apex Holdings will also issue equity interests to management rollover participants and co-investors, as described in Sections 4.2 and 4.4 below. Apex Holdings has not conducted any business operations since its formation, other than activities incidental to its formation and in connection with the Transaction. A copy of the Certificate of Incorporation of Apex Holdings is attached hereto as Exhibit C-1.
2.2.2 Ardent Apex Merger Sub Inc.
Ardent Apex Merger Sub Inc. ("Merger Sub") is a Delaware corporation formed on March 7, 2025, exclusively for the purpose of effecting the reverse triangular merger contemplated by the Merger Agreement. Merger Sub's EIN is 93-2178502. Its registered agent in the State of Delaware is National Registered Agents of Delaware, Inc., located at 160 Greentree Drive, Suite 101, Dover, DE 19904.
Merger Sub is wholly owned by Apex Holdings. Pursuant to the Merger Agreement, Merger Sub will merge with and into Luminex Systems Holdings Inc. at the effective time of the Merger, at which point Merger Sub will cease to exist as a separate entity. Merger Sub has not conducted any business operations since its formation, other than activities incidental to its formation and in connection with the Transaction. A copy of the Certificate of Incorporation of Merger Sub is attached hereto as Exhibit C-2.
2.3 The Target — Luminex Systems Holdings Inc.
2.3.1 Entity Information
Luminex Systems Holdings Inc. ("Luminex Holdings" or the "Target") is a Delaware corporation incorporated on June 14, 2021. The Target's EIN is 86-2547193. The Target's operational headquarters are located at 2100 Reston Gateway Drive, Suite 800, Reston, VA 20191. The Target's registered agent in the State of Delaware is Capitol Corporate Services, Inc., located at 1675 South Ashbury Asset Advisors, Suite B, Dover, DE 19901.
Luminex Holdings was established in 2021 as part of a reorganization of the Luminex corporate group (the "2021 Reorganization"), pursuant to which a new U.S. holding company (Luminex Holdings) was created as the ultimate parent entity of the Luminex group. Prior to the 2021 Reorganization, Luminex Systems AG, a Swiss Aktiengesellschaft, served as the ultimate parent of the group. In connection with the 2021 Reorganization, each outstanding share of Luminex AG was exchanged on a one-for-one basis for a share of Luminex Holdings common stock pursuant to a share exchange agreement. Following the 2021 Reorganization, Luminex Holdings became the direct parent of Luminex AG and the indirect parent of all operating subsidiaries, and Luminex AG became an intermediate holding company and operating entity within the group. The 2021 Reorganization was undertaken for capital markets, governance, and tax planning purposes.
A copy of the Certificate of Incorporation of Luminex Holdings, as amended, is attached hereto as Exhibit C-3.
2.3.2 Pre-Transaction Ownership
As of the date of this Notice, the outstanding equity of Luminex Systems Holdings Inc. is held as follows (on a fully diluted basis):
Ridgeline Growth Equity Fund II LP ("Ridgeline") is the majority stockholder of Luminex Holdings, holding approximately 52% of the fully diluted equity. Ridgeline is a Delaware limited partnership. Its general partner is Ridgeline Growth Equity GP II LLC, a Delaware limited liability company. The Managing Partner of Ridgeline is Jonathan Ashford. Ridgeline is a U.S.-domiciled growth equity fund focused on enterprise software and SaaS investments.
Meridian Venture Partners IV LP ("Meridian") is a significant minority stockholder, holding approximately 20% of the fully diluted equity. Meridian is a Delaware limited partnership. Its general partner is Meridian Venture GP IV LLC, a Delaware limited liability company. The Managing Partner of Meridian is Claire Fujimoto. Meridian is a U.S.-domiciled venture capital fund focused on early-stage and growth-stage technology investments.
Management and Employees collectively hold approximately 28% of the fully diluted equity of Luminex Holdings, consisting of common stock, restricted stock, and vested and unvested stock options. The key management holders are as follows:
• Dr. Stefan Kessler, Chief Executive Officer — approximately 8.5% (fully diluted)
• Annelise Gruber, Chief Financial Officer — approximately 4.2% (fully diluted)
• Dr. Markus Vogt, Chief Technology Officer — approximately 3.8% (fully diluted)
• Other management and employees — approximately 11.5% (fully diluted)
2.3.3 Board of Directors and Senior Management
The current members of the Board of Directors and senior management of Luminex Systems Holdings Inc. are as follows:
Board of Directors:
Senior Management:
2.4 Target Subsidiaries
The following entities are direct or indirect subsidiaries of Luminex Systems Holdings Inc.:
2.4.1 Luminex Systems AG (Intermediate Swiss Holding / Operating Entity)
Luminex Systems AG ("Luminex AG") is a Swiss Aktiengesellschaft registered in the Canton of Glenrock Assurance under Commercial Register No. CHE-284.391.057. Luminex AG's registered office and principal place of business are located at Bahnhofstrasse 71, 8001 Zürich, Switzerland. Luminex AG was founded in 2009 and served as the original parent entity of the Luminex group prior to the 2021 Reorganization. Following the 2021 Reorganization, Luminex AG became a wholly owned subsidiary of Luminex Holdings and now serves as the intermediate holding company for the group's non-U.S. operations, as well as an operating entity.
Luminex AG employs approximately 4,200 persons globally, including employees of its subsidiaries. For the fiscal year ended December 31, 2024, the Luminex group reported consolidated revenue of approximately $487,000,000, of which approximately $441,000,000 constituted annual recurring revenue ("ARR") from SaaS subscriptions and approximately $46,000,000 constituted professional services revenue. Consolidated adjusted EBITDA for fiscal year 2024 was approximately $121,800,000, representing a margin of approximately 25.0%.
2.4.2 Luminex Systems Inc. (U.S. Operating Subsidiary)
Luminex Systems Inc. ("Luminex US") is a Delaware corporation with EIN 86-2547210. Luminex US is headquartered at 2100 Reston Gateway Drive, Suite 800, Reston, VA 20191, co-located with the Target's operational headquarters. Luminex US is a wholly owned subsidiary of Luminex Systems Holdings Inc. and is the primary U.S. operating entity of the Luminex group.
Luminex US employs approximately 1,650 persons in the United States, including software engineers, product managers, sales and marketing professionals, customer success teams, and administrative personnel. For the fiscal year ended December 31, 2024, Luminex US generated U.S. revenue of approximately $194,800,000, representing approximately 40% of the Luminex group's consolidated global revenue.
Luminex US is the entity that holds the U.S. government contracts with DOD, DOE, and GSA, which are described in detail in Part III below. Luminex US is also the entity that is the principal focus of the CFIUS analysis in this Notice, as it constitutes the "U.S. business" within the meaning of the Regulations.
2.4.3 Luminex Systems UK Ltd.
Luminex Systems UK Ltd. ("Luminex UK") is a private limited company organized under the laws of England and Wales, with Company No. 12847362. Luminex UK's registered office is located at 14 Broadwick Street, London W1F 8HN, United Kingdom. Luminex UK is a wholly owned subsidiary of Luminex AG and serves as the regional operating entity for the United Kingdom and Nordics markets. Luminex UK employs approximately 380 persons.
2.4.4 Luminex Systems GmbH
Luminex Systems GmbH ("Veltronix GmbH") is a German Gesellschaft mit beschränkter Haftung (limited liability company) registered with the Munich Commercial Register under HRB No. HRB 247891. Veltronix GmbH's registered office is located at Leopoldstrasse 120, 80802 Munich, Germany. Veltronix GmbH is a wholly owned subsidiary of Luminex AG and serves as the regional operating entity for the DACH region (Germany, Austria, and Switzerland). For the fiscal year ended December 31, 2024, Veltronix GmbH generated revenue of approximately €67,000,000. Veltronix GmbH employs approximately 950 persons.
2.4.5 Luminex Systems Pte. Ltd.
Luminex Systems Pte. Ltd. ("Luminex Singapore") is a Singapore private limited company with Unique Entity Number (UEN) 201924781K. Luminex Singapore's registered office is located at 8 Marina Boulevard, #36-01, Singapore 018981. Luminex Singapore is a wholly owned subsidiary of Luminex AG and serves as the regional operating entity for the Asia-Pacific region. Luminex Singapore employs approximately 220 persons.
2.5 Seller Entities
The following entities and individuals will sell equity interests in Luminex Systems Holdings Inc. in connection with the Transaction:
Ridgeline Growth Equity Fund II LP. As the majority stockholder (52% fully diluted), Ridgeline will sell all of its shares of Luminex Holdings common stock and is expected to receive approximately $1,456,000,000 in cash merger consideration at the closing. Ridgeline will not retain any equity interest in the post-closing entity.
Meridian Venture Partners IV LP. As a significant minority stockholder (20% fully diluted), Meridian will sell all of its shares of Luminex Holdings common stock and is expected to receive approximately $560,000,000 in cash merger consideration at the closing. Meridian will not retain any equity interest in the post-closing entity.
Management Rollover Participants. Certain members of the Target's management team will participate in a management equity rollover in connection with the Transaction. Management holders collectively own approximately 28% of the fully diluted equity of Luminex Holdings, with an aggregate equity value of approximately $784,000,000 at the per-share merger consideration price of $20.00. Of this amount, management holders will receive cash consideration of approximately $378,980,000, and will roll over the remaining equity value of approximately $405,020,000 into equity interests in Ardent Apex Holdings Inc. The rollover equity will be subject to a stockholders agreement governing transfer restrictions, tag-along and drag-along rights, board composition, and information rights, as described in Section 4.4 below. The principal management rollover participants are Dr. Stefan Kessler, Annelise Gruber, and Dr. Markus Vogt.
2.6 Key Advisors
The following advisors are engaged by the Transaction Parties in connection with the Transaction:
Buyer's Advisors:
Seller's Advisors:
PART III — DESCRIPTION OF THE U.S. BUSINESS
3.1 Overview of Luminex Systems Inc. and Its Products
Luminex Systems Inc. is a cloud-based enterprise software-as-a-service ("SaaS") company that develops, markets, and supports the "Luminex One" platform. The Luminex One platform is an integrated suite of enterprise applications encompassing three core functional modules: (i) enterprise resource planning ("ERP"), (ii) procurement automation, and (iii) supply-chain analytics. The platform is designed to enable large and mid-market enterprises to manage end-to-end business processes, from financial management and human resources to procurement workflows, vendor management, inventory optimization, and supply-chain visibility.
The Luminex One platform is delivered exclusively as a cloud-hosted SaaS solution, with customers accessing the platform through web browsers and mobile applications on a subscription basis. The platform is built on a modern, multi-tenant cloud architecture leveraging Ridgeway Industries ("Meridian Technologies") and Crestline Systems infrastructure, with data residency options that allow customers to specify the geographic location of their data storage (including dedicated U.S. data centers for U.S. government and regulated-industry customers, as discussed further below).
Luminex's key markets are distributed globally, with the following approximate revenue breakdown by region for fiscal year 2024:
U.S. operations represent the single largest national market for the Luminex group. For the fiscal year ended December 31, 2024, Luminex US generated U.S. revenue of approximately $194,800,000, representing 40% of the Luminex group's consolidated global revenue of $487,000,000. The U.S. customer base includes large enterprises across the financial services, manufacturing, technology, healthcare, and public sector verticals.
Luminex US employs approximately 1,650 persons in the United States, primarily based at its operational headquarters in Reston, Virginia, with additional personnel in satellite offices in San Francisco, California, and Austin, Texas. The U.S. workforce includes software engineers, product managers, data scientists, sales and marketing professionals, customer success and support teams, professional services consultants, and administrative and corporate personnel.
The principal U.S. office is located at 2100 Reston Gateway Drive, Suite 800, Reston, VA 20191. Additional U.S. office locations include 100 Pine Street, Suite 3200, San Francisco, CA 94111, and 9600 Great Hills Trail, Suite 200W, Austin, TX 78759.
3.2 U.S. Government Contracts
Luminex US currently holds contracts with three U.S. federal agencies, which constitute the principal basis for the Transaction Parties' determination that CFIUS jurisdiction exists and that a voluntary joint notice is appropriate. Each of these contracts is summarized below, with additional detail provided in Exhibit D.
3.2.1 Department of Defense — Logistics Software Module
Luminex US provides a specialized logistics software module within the Luminex One platform to a component of the U.S. Department of Defense (the specific component is identified in Exhibit D-1, which is submitted under a request for confidential treatment). This logistics software module is used by the DOD component for supply-chain management, logistics tracking, inventory management, and procurement workflow automation. The module is a customized configuration of the Luminex One platform's supply-chain analytics and procurement-automation capabilities, tailored to meet the specific operational requirements of the DOD component.
The contract scope includes the initial procurement and deployment of the software module, including configuration, customization, data migration, and integration with existing DOD information systems, as well as ongoing SaaS subscription and maintenance services, including software updates, patches, security enhancements, and technical support. The contract was awarded following a competitive procurement process and is structured as a firm-fixed-price contract with option years.
In the performance of this contract, Luminex US personnel may have access to DOD logistics and supply-chain data, which may include controlled unclassified information ("CUI") as defined under 32 C.F.R. Part 2002. The nature and sensitivity of the data accessible to Luminex US personnel are described in greater detail in Exhibit D-1. Luminex US has implemented data-handling procedures and access controls consistent with NIST Special Publication 800-171 ("Protecting Controlled Unclassified Information in Nonfederal Systems and Organizations") and is in the process of achieving Cybersecurity Maturity Model Certification ("CMMC") Level 2 compliance.
To the extent that the DOD contract requires any facility security clearances or personnel security clearances under the National Industrial Security Program Operating Manual ("NISPOM"), the Transaction Parties will provide a detailed description of such clearances in a supplemental filing. The specific contract value, term, and additional details are set forth in Exhibit D-1.
3.2.2 Department of Energy — Procurement Platform
Luminex US provides its procurement-automation module to the U.S. Department of Energy for agency-wide procurement workflow management. The DOE uses the Luminex One procurement module to manage requisition, approval, sourcing, purchase order, and invoice processing workflows across multiple DOE offices and facilities. The platform enables DOE procurement professionals to automate routine procurement tasks, enforce compliance with federal acquisition regulations, and generate analytics and reporting on procurement activity.
In the performance of this contract, Luminex US personnel may have access to DOE procurement records, vendor databases, and related administrative data. While the majority of this data is administrative in nature, the Transaction Parties recognize that certain procurement records may contain information related to energy infrastructure, national laboratories, or other sensitive DOE programs. The Transaction Parties are in the process of conducting a detailed assessment of the sensitivity of the data accessible under this contract and will provide additional information as appropriate.
Luminex US complies with all applicable federal information security standards in connection with its DOE contract, including the Federal Information Security Modernization Act ("FISMA"), NIST Special Publication 800-53 ("Security and Privacy Controls for Information Systems and Organizations"), and applicable DOE-specific cybersecurity requirements. The specific contract value, term, security requirements, and additional details are set forth in Exhibit D-2.
3.2.3 General Services Administration — Enterprise License
Luminex US holds an enterprise license agreement with the U.S. General Services Administration, which enables multiple federal agencies to access the Luminex One platform through GSA's government-wide procurement vehicle. The GSA enterprise license agreement is structured as a blanket purchase agreement under GSA Schedule 70 (now consolidated into GSA's Multiple Award Schedule), allowing federal agencies to place task orders for Luminex One platform subscriptions, configuration services, and professional services through a streamlined procurement process.
The GSA enterprise license agreement significantly expands the potential scope of Luminex US's involvement with U.S. federal agencies, as it provides a procurement vehicle through which any federal civilian agency (and, in some cases, DOD components) may acquire Luminex One platform services. As of the date of this Notice, task orders have been placed under the GSA enterprise license agreement by several federal agencies, including but not limited to the Department of Health and Human Services, the Department of the Treasury, and the Small Business Administration. The full list of agencies that have placed task orders under the GSA enterprise license agreement is provided in Exhibit D-3.
The GSA enterprise license agreement carries broader implications for federal data handling, as each task order may involve different types of agency data with varying sensitivity levels. Luminex US maintains compliance with all applicable data-handling requirements under FISMA, FedRAMP (Luminex One holds a FedRAMP Moderate authorization through the Joint Authorization Board), and agency-specific security standards. The contract value, term, and additional details are set forth in Exhibit D-3.
3.3 Sensitive Technology and Data
The Transaction Parties have undertaken a thorough assessment of whether Luminex US produces, designs, tests, manufactures, fabricates, or develops any "critical technologies" within the meaning of 31 C.F.R. § 800.215. The term "critical technologies" includes, among other things, defense articles and defense services included on the United States Munitions List set forth in the International Traffic in Arms Regulations ("ITAR") (22 C.F.R. Parts 120–130), items included on the Commerce Control List set forth in the Export Administration Regulations ("EAR") (15 C.F.R. Part 774), and certain other controlled items.
Based on the Transaction Parties' analysis to date, the Luminex One platform is a commercial enterprise software application that does not appear to constitute a "critical technology" under any of the enumerated categories in 31 C.F.R. § 800.215. The platform is not listed on the United States Munitions List, is not believed to be controlled under the EAR (other than as EAR99 or possibly under the general software and technology categories applicable to commercially available software), and is not subject to ITAR controls. The Transaction Parties note, however, that the customized logistics module provided to DOD under the contract described in Section 3.2.1 above may involve technology or software that is subject to more detailed export control analysis, and the Transaction Parties are in the process of completing this analysis. Any additional findings will be provided to CFIUS in a supplemental filing.
The Transaction Parties have also assessed whether Luminex US maintains or collects "sensitive personal data" of U.S. citizens as defined under 31 C.F.R. § 800.241. The Luminex One platform is primarily an enterprise business application that processes business data (e.g., financial records, procurement data, supply-chain information, and vendor management data) rather than personal data of individual U.S. persons. However, to the extent that certain modules of the platform involve human resources or employee data of Luminex US's enterprise customers, or to the extent that federal agency data accessible through government contracts includes personally identifiable information ("PII") of government employees, the platform may process limited categories of personal data. The Transaction Parties are conducting a detailed data-mapping exercise to determine the precise types and volumes of personal data processed by Luminex US and will provide the results to CFIUS upon completion.
With respect to the Luminex One platform architecture and data security:
• Cloud Hosting: The Luminex One platform is hosted on Meridian Technologies and Crestline Systems cloud infrastructure, with multi-region deployment capabilities.
• Data Residency: For U.S. government customers, Luminex US maintains dedicated instances of the Luminex One platform hosted in U.S.-based data centers (specifically, Meridian Technologies GovCloud regions located in the continental United States). All data associated with U.S. government contracts is stored and processed exclusively within U.S.-based data centers, with no data replication or transfer to non-U.S. locations.
• Encryption: All data at rest is encrypted using AES-256 encryption, and all data in transit is encrypted using TLS 1.2 or higher. Encryption keys for government customer data are managed through Meridian Technologies Key Management Service (KMS) with customer-managed keys where required.
• Access Controls: Luminex US employs role-based access control ("RBAC"), multi-factor authentication ("MFA"), and least-privilege principles to restrict access to government customer data to authorized personnel only. Access logs are maintained and auditable.
• FedRAMP Authorization: The Luminex One platform holds a FedRAMP Moderate authorization through the Joint Authorization Board ("JAB"), which certifies compliance with NIST SP 800-53 security controls at the Moderate baseline level.
The Transaction Parties do not believe that any Luminex technology is currently subject to export controls under ITAR or the EAR beyond the general applicability of EAR99 classification to commercially available software. However, the Transaction Parties are completing a detailed export control classification review and will supplement this Notice with any relevant findings.
3.4 Critical Infrastructure
The Transaction Parties have analyzed whether Luminex US's services to DOD, DOE, and GSA implicate any of the 16 critical infrastructure sectors identified in Presidential Policy Directive 21 ("PPD-21"), which are relevant to the TID U.S. business analysis under the Regulations and to CFIUS's broader national security assessment.
Based on this analysis, the Transaction Parties have identified the following potential nexuses between Luminex US's operations and critical infrastructure sectors:
• Defense Industrial Base Sector. Luminex US's contract with DOD to provide a logistics software module for supply-chain management and logistics tracking has a direct nexus to the Defense Industrial Base sector. The DOD logistics software module supports the management and tracking of defense-related supply chains, and disruption or compromise of this module could potentially affect DOD logistics operations. The Transaction Parties recognize that this nexus is a significant factor in the CFIUS analysis and have proposed mitigation measures to address associated risks, as described in Part VI below.
• Energy Sector. Luminex US's contract with DOE to provide a procurement-automation platform has a potential nexus to the Energy sector. To the extent that DOE procurement records accessible through the Luminex One platform relate to energy infrastructure, national laboratories, or other sensitive energy programs, the platform's involvement in DOE procurement workflows may implicate Energy sector critical infrastructure considerations. The Transaction Parties are assessing the specific nature of the DOE data accessible through the contract and will provide additional detail.
• Critical Manufacturing and Transportation Systems Sectors. The Luminex One platform's supply-chain analytics functionality may have indirect relevance to the Critical Manufacturing and Transportation Systems sectors through downstream use by government customers. Specifically, to the extent that DOD or other federal agencies use the Luminex One platform to manage supply chains that include critical manufacturing inputs or transportation logistics, the platform's functionality may have a tangential connection to these sectors. The Transaction Parties note, however, that this connection is indirect and mediated by the government customer's own use of the platform, rather than a direct provision of critical infrastructure services by Luminex US.
The Transaction Parties are prepared to discuss these critical infrastructure nexuses with CFIUS and its member agencies in greater detail and to provide any additional information that may be requested.
3.5 Proximity to Sensitive Government Facilities
The Transaction Parties have assessed the geographic locations of Luminex US's offices and data center facilities for proximity to sensitive U.S. government installations. The principal U.S. office of Luminex US is located at 2100 Reston Gateway Drive, Suite 800, Reston, VA 20191, in the Dulles Technology Corridor of Northern Virginia. This location is within the Washington, D.C. metropolitan area and is in proximity to numerous DOD, intelligence community, and other federal government facilities, including but not limited to the Pentagon, the National Geospatial-intelligence Agency headquarters, and various intelligence community installations in Northern Virginia.
Luminex US also maintains satellite offices at 100 Pine Street, Suite 3200, San Francisco, CA 94111, and 9600 Great Hills Trail, Suite 200W, Austin, TX 78759. The Transaction Parties are not aware of any particular proximity concerns associated with these locations.
With respect to data centers, as noted in Section 3.3 above, Luminex US utilizes Meridian Technologies GovCloud regions for U.S. government customer data. These data centers are operated by Ridgeway Industries and are located in the continental United States. Luminex US does not own or operate any proprietary data center facilities.
The Transaction Parties are prepared to provide any additional information regarding the geographic locations of Luminex US's facilities that CFIUS may require.
PART IV — TRANSACTION STRUCTURE AND MECHANICS
4.1 Merger Structure
The Transaction is structured as a reverse triangular merger under the DGCL. The material steps of the Transaction are as follows:
1. Ardent Apex Merger Sub Inc. (a wholly owned subsidiary of Ardent Apex Holdings Inc.) will merge with and into Luminex Systems Holdings Inc. at the effective time of the Merger (the "Effective Time").
2. At the Effective Time, Merger Sub will cease to exist as a separate entity, and Luminex Systems Holdings Inc. will continue as the surviving corporation and a wholly owned subsidiary of Ardent Apex Holdings Inc.
3. At the Effective Time, each share of Luminex Holdings common stock outstanding immediately prior to the Effective Time (other than shares held by stockholders who have validly exercised appraisal rights under DGCL Section 262, shares held by Luminex Holdings as treasury shares, and shares subject to management rollover agreements) will be converted into the right to receive $20.00 per share in cash, without interest.
4. Shares subject to management rollover agreements will be exchanged for equity interests in Ardent Apex Holdings Inc. in accordance with the terms of the applicable rollover agreements, as described in Section 4.2 below.
Following the closing of the Transaction, the post-closing organizational structure will be as follows:
Ardent Capital Partners III LP (Delaware limited partnership; ultimate controlling entity)
Ardent Apex Holdings Inc. (Delaware corporation; direct parent)
Luminex Systems Holdings Inc. (Delaware corporation; surviving corporation)
Luminex Systems AG (Swiss Aktiengesellschaft; intermediate holding / operating entity)
Luminex Systems Inc. (Delaware corporation; U.S. operating subsidiary) Luminex Systems UK Ltd. (England and Wales; UK / Nordics operating subsidiary) Luminex Systems GmbH (German GmbH; DACH operating subsidiary) Luminex Systems Pte. Ltd. (Singapore; APAC operating subsidiary)
A detailed pre-transaction and post-transaction organizational chart is attached hereto as Exhibit A.
4.2 Consideration
The aggregate equity consideration for the Transaction is $2,800,000,000, reflecting a per-share merger consideration of $20.00 multiplied by approximately 140,000,000 fully diluted shares. The consideration is payable in cash, except for the management rollover equity described below.
The allocation of merger consideration among the stockholder groups is as follows:
The management rollover equity of approximately $405,020,000 will be contributed by the management rollover participants (principally Dr. Stefan Kessler, Annelise Gruber, and Dr. Markus Vogt, together with other participating management and employees) in exchange for equity interests in Ardent Apex Holdings Inc., the post-closing parent entity. The rollover equity will represent a minority interest in Apex Holdings and will be subject to the terms of a stockholders agreement, as described in Section 4.4 below.
The Merger Agreement provides for a purchase price escrow of $140,000,000, representing 5% of the aggregate equity consideration. The escrow will be held by Continental Fiduciary Trust Company, as escrow agent, for a period of 18 months following the closing, to secure the sellers' indemnification obligations under the Merger Agreement with respect to breaches of representations and warranties, covenants, and other specified matters.
4.3 Financing
The Transaction will be financed through a combination of equity and debt as follows:
Sources of Funds:
Uses of Funds:
Debt Financing. The senior secured Term Loan B of $1,200,000,000 will be provided by Stonebridge Credit Partners LLC as lead arranger and administrative agent, with Birchwood Capital Finance LLC ($350,000,000 hold) and Ironvale Credit Fund III LP ($250,000,000 hold) as co-lenders. The remaining $250,000,000 of the Term Loan B is expected to be syndicated to additional institutional lenders in the ordinary course. The Term Loan B will bear interest at a rate of SOFR plus 475 basis points, with a seven-year maturity. The commitment letter for the senior secured credit facility was executed on March 8, 2025 (Stonebridge Reference No. SC-2025-0312-AC). A copy of the commitment letter is attached hereto as Exhibit B-4.
The subordinated notes of $300,000,000 will be issued to Crestline Mezzanine Partners II LP. The subordinated notes will bear interest at a rate of 11.5% per annum on a PIK toggle basis, with an eight-year maturity. A copy of the subordinated note purchase agreement is attached hereto as Exhibit B-5.
The revolving credit facility of $200,000,000 will be provided by Stonebridge Credit Partners LLC as administrative agent, as part of the senior secured credit facility. The revolving credit facility is expected to be undrawn at the closing and is intended to be available for general corporate and working capital purposes post-closing.
Equity Financing. The equity financing for the Transaction consists of (i) the Fund equity commitment of $695,980,000 from Ardent Capital Partners III LP, (ii) the management rollover equity of approximately $405,020,000, and (iii) co-investment equity of $300,000,000 ($200,000,000 from Northvale and $100,000,000 from Summit Ridge). Copies of the equity commitment letter from Ardent Capital Partners III LP and the co-investment agreements with Northvale and Summit Ridge are attached hereto as Exhibits B-2 and B-3, respectively.
4.4 Post-Closing Governance
Following the closing of the Transaction, Ardent Capital will exercise control over the post-closing entity structure through the following governance mechanisms:
Ardent Capital GP III LLC (the General Partner of the Fund) will have sole and exclusive authority to manage the business and affairs of Ardent Capital Partners III LP, including the exercise of the Fund's rights as the controlling stockholder of Ardent Apex Holdings Inc. The managing members of the General Partner — Ted Hargrove and Victoria Langford — are U.S. citizens and will continue to exercise ultimate decision-making authority over the Fund's investment and governance activities.
Board of Directors of Ardent Apex Holdings Inc. The board of directors of Apex Holdings will be designated by Ardent Capital, in its capacity as the controlling stockholder. The initial post-closing board is expected to consist of five directors, of whom three will be designated by Ardent Capital (including Ted Hargrove and Victoria Langford), one will be an independent director, and one will be Dr. Stefan Kessler (in his capacity as CEO and management equity holder). No co-investor, limited partner, or other third party will have the right to designate a member of the board of directors.
Management Rollover Participants. Dr. Stefan Kessler, Annelise Gruber, and Dr. Markus Vogt will hold minority equity interests in Apex Holdings through the management rollover and will continue in their current management roles. Their equity interests will be governed by a stockholders agreement that provides for customary transfer restrictions (including restrictions on transfer without Ardent Capital's consent), tag-along and drag-along rights, and limited information rights. The management rollover participants will not have board designation rights (other than Dr. Kessler's seat as described above), veto rights over material corporate actions, or any other governance rights that would constitute "control" within the meaning of the Regulations.
Co-Investor Rights. Northvale and Summit Ridge will hold minority equity interests in Apex Holdings through the co-investment. Their rights are limited to economic rights (distributions pro rata), customary information rights (periodic financial reporting), and tag-along and drag-along rights. Neither Northvale nor Summit Ridge will have board designation rights, veto rights, access to material non-public technical information of Luminex US, or any right to participate in or influence the management, operations, or strategic direction of the post-closing entity or its subsidiaries.
4.5 Conditions to Closing
The closing of the Transaction is subject to the satisfaction or waiver of the following conditions precedent, as set forth in the Merger Agreement:
(a) Regulatory Approvals. Receipt of the following regulatory approvals or expiration of applicable waiting periods: (i) HSR Act clearance (expiration or early termination of the waiting period, or compliance with any Second Request); (ii) CFIUS clearance (written notification from CFIUS that the Committee has concluded its review and determined that there are no unresolved national security concerns, or that the Committee has concluded action under Section 721); (iii) Swiss FINMA/SECO clearance; (iv) Bundeskartellamt clearance; and (v) EU Foreign Subsidies Regulation clearance.
(b) No Material Adverse Effect. No material adverse effect shall have occurred with respect to the Target between the date of the Merger Agreement and the closing date.
(c) Bring-Down of Representations and Warranties. The representations and warranties of each party contained in the Merger Agreement shall be true and correct in all material respects (or, with respect to representations qualified by materiality, in all respects) as of the closing date.
(d) Compliance with Covenants. Each party shall have complied in all material respects with its covenants and obligations under the Merger Agreement.
(e) No Injunctions or Restraints. No law, order, injunction, or decree shall have been enacted, entered, promulgated, or enforced by any governmental authority that prohibits, restrains, or makes illegal the consummation of the Transaction.
The Merger Agreement provides for an outside date of September 10, 2025, after which either party may terminate the agreement if the closing has not occurred. The outside date is automatically extended to December 10, 2025 if the sole unsatisfied condition to closing as of September 10, 2025 is the receipt of one or more required regulatory approvals and all other conditions to closing have been satisfied or are capable of being satisfied.
PART V — BASIS FOR COVERED TRANSACTION DETERMINATION
5.1 Statutory and Regulatory Framework
Section 721 of the Defense Production Act of 1950, as amended by FIRRMA (50 U.S.C. § 4565), authorizes the President of the United States, acting through CFIUS, to review certain transactions involving foreign investment in the United States for national security implications. The implementing regulations, set forth at 31 C.F.R. Part 800, define the scope of "covered transactions" that are subject to CFIUS jurisdiction and establish the procedures for voluntary notices, declarations, and reviews.
Under 31 C.F.R. § 800.213, a "covered transaction" includes any transaction by or with any foreign person that could result in foreign control of any U.S. business, as well as certain non-controlling investments by foreign persons in a "TID U.S. business" (i.e., a U.S. business that produces, designs, tests, manufactures, fabricates, or develops one or more critical technologies; performs certain functions with respect to covered investment critical infrastructure; or maintains or collects sensitive personal data of U.S. citizens).
The Transaction Parties have analyzed the proposed Transaction under this framework and, for the reasons set forth below, have concluded that the Transaction warrants a voluntary joint notice to CFIUS.
5.2 Foreign Person Analysis
The analysis of whether the Transaction involves a "foreign person" within the meaning of 31 C.F.R. § 800.224 requires a careful examination of the acquiring entity chain and the identity and governance rights of all investors in the acquiring structure.
Ardent Capital Partners III LP and Its General Partner. The ultimate acquiring entity, Ardent Capital Partners III LP, is a Delaware limited partnership. Its general partner, Ardent Capital GP III LLC, is a Delaware limited liability company. The managing members of the General Partner — Ted Hargrove and Victoria Langford — are U.S. citizens and U.S. residents. All five members of the Fund's Investment Committee are U.S. citizens. The Fund is organized, headquartered, and managed in the United States. On its face, the Fund and its General Partner are U.S. persons.
Luminex Systems AG — Swiss Entity in the Acquisition Chain. The Transaction involves the indirect acquisition of Luminex Systems AG, a Swiss Aktiengesellschaft, which is the direct parent of Luminex US and the other operating subsidiaries. Following the 2021 Reorganization, Luminex AG became a wholly owned subsidiary of Luminex Holdings (a Delaware corporation). The post-closing structure places Luminex AG within a chain controlled by Ardent Capital (a U.S. fund), with Ardent Apex Holdings Inc. (a Delaware corporation) as the direct parent of Luminex Holdings, which in turn is the direct parent of Luminex AG. Although Luminex AG is a Swiss entity, it will be controlled post-closing by U.S. persons through the Ardent Capital fund structure. The CFIUS analysis therefore focuses on whether any foreign person within the Ardent Capital fund structure obtains "control" or a covered non-controlling investment interest in the U.S. business.
Northvale Sovereign Holdings Ltd. Northvale is an exempted limited company registered in the Cayman Islands. The primary point of contact for Northvale is Ahmad Al-Rashid, Head of Direct Investments. A detailed disclosure of Northvale's ultimate beneficial ownership and any foreign government connections is provided in Exhibit E-2. The Transaction Parties have assessed whether Northvale or its beneficial owners constitute a "foreign person"

PRIVILEGED & CONFIDENTIAL — ATTORNEY WORK PRODUCT — SUBJECT TO FURTHER REVIEW AND REVISION PRIOR TO SUBMISSION

Record

Parties

Dates

Amounts